GAM
TMDX icon

Gemmer Asset Management’s Transmedics TMDX Stock Holding History

Gemmer Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-120
Closed -$4K – 1435
2021
Q2 		$4K Buy
+120
New +$3.33K ﹤0.01% 1218

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gemmer Asset Management's TMDX Position: Q3 2021 in Review

Gemmer Asset Management sold out of Transmedics (TMDX) in Q3 2021, closing a stake of 120 shares — an estimated $4K sold.

Gemmer Asset Management first reported a position in TMDX in Q2 2021 and held it in 1 quarter. The position peaked at $4K in Q2 2021. 120 funds tracked by Wall St. Rank hold TMDX as of Q3 2021.

  • Gemmer Asset Management reported no remaining Transmedics position as of Q3 2021 after selling out during the quarter.
  • Gemmer Asset Management sold 120 Transmedics shares in Q3 2021, an estimated $4K.
  • Gemmer Asset Management first reported a position in Transmedics in Q2 2021 and held it in 1 quarter.
  • Gemmer Asset Management's Transmedics position peaked at $4K in Q2 2021.
  • 120 funds tracked by Wall St. Rank held Transmedics as of Q3 2021.

Based on Gemmer Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.